To investigate whether the EBF1, MYO6 and CALR differential expression could be an age-independent signature to predict R-CHOP response, we assessed their expression levels in a heterogeneous age group, which revealed a comparable expression level in adults as well as elderly DLBCL patients (Figure 4A). Here, EBF1 is linked to diffuse large B-cell lymphoma.